You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

K3-CpG ODN

Showing 1 - 25 of 353
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-OX40 Antibody BMS 986178
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 3, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Palo Alto (Ibrutinib, Radiation

Active, not recruiting
  • Grade 1 Follicular Lymphoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 13, 2022

Covid19 Trial in Ankara, Istanbul, Kocaeli (SARS-CoV-2 VLP Vaccine-Wuhan, SARS-CoV-2 VLP Vaccine-Alpha (British) variant,

Completed
  • Covid19
  • SARS-CoV-2 VLP Vaccine-Wuhan
  • +2 more
  • Ankara, Turkey
  • +2 more
May 24, 2022

Covid19 Trial in Ankara (SARS-CoV-2 VLP Vaccine, Placebo)

Completed
  • Covid19
  • SARS-CoV-2 VLP Vaccine
  • Placebo
  • Ankara, Turkey
    Dr. Abdurahman Yurtaslan Ankara Oncology Training and Research H
May 24, 2022

Lung Cancer, Hepatocellular Carcinoma, Solid Tumor Trial in Guangzhou (CpG-ODN)

Recruiting
  • Lung Cancer
  • +2 more
  • CpG-ODN
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Jun 27, 2021

Clinical Practice Guidelines, Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Below Knee (Injury) Trial in

Completed
  • Clinical Practice Guidelines
  • +7 more
  • Telehealth-based strategy
  • Medellín, Antioquia, Colombia
    Universidad de Antioquia
Nov 2, 2022

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • (no location specified)
Jan 3, 2023

Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-OX40 Antibody BMS 986178
  • TLR9 Agonist SD-101
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 13, 2022

Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • IRE plus checkpoint inhibitor
  • IRE plus Checkpoint Inhibitor plus CpG-ODN
  • (no location specified)
Sep 13, 2023

Effectiveness of Standard Therapy of Acne Vulgaris

Completed
  • Acne Vulgaris
    • Jakarta Pusat, Jakarta, Indonesia
      dr.Cipto Mangunkusumo National Central General Hospital
    Aug 7, 2023

    Malignant Melanoma Trial in Amsterdam (Tilsotolimod, Saline (0.9% sodium chloride))

    Recruiting
    • Malignant Melanoma
    • Amsterdam, Netherlands
      VU Medical Centere
    Apr 14, 2021

    Pain, Dementia Trial (Pain-CPG-EIT, Pain-CPG-Education Only)

    Not yet recruiting
    • Pain
    • Dementia
    • Pain-CPG-EIT
    • Pain-CPG-Education Only
    • (no location specified)
    May 12, 2023

    Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)

    Completed
    Has Results
    • Cancer
    • Neoplasm
    • NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
    • Frankfurt, Germany
      Krankenhaus Nordwest
    Oct 3, 2022

    Healthcare Worker, Hepatitis B Vaccine, Nonresponder Trial in Madison (Recombinant hepatitis B vaccine with CpG adjuvant)

    Recruiting
    • Healthcare Worker, Hepatitis B Vaccine, Nonresponder
    • Recombinant hepatitis B vaccine with CpG adjuvant
    • Madison, Wisconsin
      University of Wisconsin
    Jul 5, 2022

    Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

    Withdrawn
    • Hepatitis B
    • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
    • Baltimore, Maryland
    • +1 more
    Jul 19, 2022

    Plague, Pneumonic, Plague, Vaccine-Preventable Diseases Trial in United States (rF1V vaccine and CpG 1018® adjuvant, rF1V

    Recruiting
    • Plague, Pneumonic
    • +2 more
    • rF1V vaccine and CpG 1018® adjuvant
    • rF1V vaccine
    • Huntsville, Alabama
    • +4 more
    Aug 16, 2022

    Prostate Cancer Trial in Frankfurt, Zurich (NY-ESO-1 protein/CpG 7909)

    Completed
    Has Results
    • Prostate Cancer
    • NY-ESO-1 protein/CpG 7909
    • Frankfurt, Germany
    • +1 more
    Jan 7, 2021

    Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

    Recruiting
    • Minimal Residual Disease
    • +11 more
    • ELI-002 2P
    • Duarte, California
    • +10 more
    Jan 18, 2023

    Systemic Lupus Erythematosus Trial in Santa Cruz de Tenerife (Multicomponent intervention)

    Completed
    • Systemic Lupus Erythematosus
    • Multicomponent intervention
    • Santa Cruz de Tenerife, Spain
      Servicio de Evaluación del Servicio Canario de la Salud
    Sep 21, 2021

    Covid19 Trial in Canada, United States (Low Dose of KBP-COVID-19, High Dose of KBP-COVID-19, Placebo)

    Active, not recruiting
    • Covid19
    • Low Dose of KBP-COVID-19
    • +2 more
    • West Palm Beach, Florida
    • +7 more
    Aug 15, 2022

    Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

    Recruiting
    • Myeloid Malignancies
    • Lymphoid Malignancies
    • NK Cell enriched-DLI only
    • NK-DLI + DUK-CPG-001
    • Durham, North Carolina
      Duke University Health System
    Mar 8, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +14 more
    • ELI-002 7P
    • (no location specified)
    Feb 3, 2023

    COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)

    Terminated
    • COVID-19
    • CpG 1018/Alum-adjuvanted SCB-2019 vaccine
    • +2 more
    • Kyiv, Ukraine
    • +3 more
    May 19, 2022

    Autoimmune Diseases, Epilepsy, Autonomic Dysfunction Trial in Louisville (Vagal nerve stimulation (VNS))

    Recruiting
    • Autoimmune Diseases
    • +3 more
    • Vagal nerve stimulation (VNS)
    • Louisville, Kentucky
    • +1 more
    Nov 7, 2022

    Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • +2 more
    • Nivolumab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Dec 16, 2021